Edwards Lifesciences’ EW fourth-quarter performance was backed by its most comprehensive structural heart disease portfolio. The Surgical Structural Heart business is benefiting from the strong ...

For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) ...

Valve‐in‐valve transcatheter aortic valve replacement (TAVR) is a recognized alternative for treating the structural valve deterioration of bioprosthetic valves. Recent guidelines and trials have ...

This multicenter study sheds more light on sex-based differences in aortic stenosis (AS) and argues the benefits of using ...

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

Nat Clin Pract Cardiovasc Med. 2008;5(12):764-765. We believe that strategies to avoid or reduce the severity of PPM should be individualized and take into account multiple variables, such as ...

The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive standard dataset of ...

ACURATE neo2 TAVI achieves high success in severe bicuspid aortic stenosis, demonstrating strong 30-day safety and efficacy.